100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Purchase Order 75F40118P10192
Award Date
7/18/18
Potential Completion Date
7/14/19
Potential Value
$10K
Overview
Contacts
Activity
1
Transactions
1
Subawards
Opportunity Stack
Similar Awards
Federal Agency
Food and Drug Administration
Awardee
Icon Clinical Research LLC EUJNKH6LE8U8
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
PSC Category
7030 - Information Technology Software
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Description
- NONMEM SOFTWARE - NECESSARY FOR CLINICAL PHARMACOLOGY REVIEWERS AND PHARMACOMETRICIANS.
Posted 7/18/18
5
1
Name
Description
Solicitation Number
FederalAgency
Type
PostedDate
Intent to Sole Source: ICON NONMEM
Added: Jun 12, 2018 5:56 pm The U.S. Food and Drug Administration (FDA), Rockville, MD intends to award a firm-fixed price contract for renewal software and maintenance of ICON NONMEM. FDA intends to issue an award, to ICON Clinical Research LLC. at 2100 Pennbrook Parkway, North Wales, PA 19454-4140.FDA's Office of Clinical Pharmacology uses ICON NONMEM to review and analyze clinical pharmacology and pharmacometric data. The deliverables include the ICON NONMEM software package, enterprise software licenses (200+ packs/800+ FCUs), maintenance/support, and software updates.There are no set-aside restrictions for this procurement, and date of delivery is anticipated to be 7/15/2018. ICON Clinical Research LLC. offers a product with capabilities that are not available from any other vendor, and controls all propriety rights for this product:1. The FDA has an ongoing business need for the ICON NONMEM software and maintenance. The annual software licensing is required by FDA to ensure continuity of operations.2. The ICON NONMEM are not available via GSA Schedule.The Government intends to solicit and negotiate with only one source under authority of FAR 6.302-1. Interested entities may identify their interest and capability to respond to the requirement or submit proposals.Interested entities offering Equal to products must demonstrate the products meet the following salient characteristics:The software must be Windows 10 64 bit compatible and capable of directly analyzing output files produced by industry sponsors using ICON NONMEM software. It must possess the following salient characteristics:o The following population analysis methods must be available: First Order Conditional Estimation (FOCE)o Laplace Conditional Estimationo Iterative Two Stage (ITS)o Importance Sampling Expectation-Maximization (IMP)o Stochastic Approximation Expectation-Maximization (SAEM)o Markov-Chain Monte Carlo Bayesian Analysis (BAYES) o Parallel computing of a single problem over multiple cores or computerso Dynamic memory allocation according to problem size.o Capable of using the first-order conditional estimation method.o Multiple mixed effects levels, with random effects across groups of individuals such as clinical siteso Symbolic reference to thetas, etas, and epsilons.o Variance matrix parameters output in covariance and correlation format.o Variance matrix parameters in covariance, correlation, or Cholesky format.o Enhanced annealing feature for SAEM to facilitate estimation of fixed effect parameters (THETAs) that do not have associated inter-subject variance (ETA's).o Boot-strap simulationso Perform Monte Carlo search of population parameters, and select the set that provides the lowest starting objective function for an estimation.o Perform Monte Carlo search for initial best estimates of etas for each subject. Together with a Monte Carlo search of best initial population parameters, this provides a global search technique for the traditional methods, with less reliance on starting position for incidence of success.o FOCE/Laplace and ITS assessment using only numerical eta derivatives for search of best etas and/or eta Hessian matrix assessment.o Conditional Individual Weighted Residual (CIWRES) added to residual variance diagnostics. Includes evaluation for L2 correlated data as well.o Allow input and reporting of thetas in their natural domain, even when linear Mu referencing.o XML report fileso Nelder-Mead optimization option for best fit individual etaso Option to use either eigenvalue square root or Cholesky square root algorithms for assessing weighted residual diagnostics.o Analytical and numerical derivatives of predicted and residual variance values with respect to etaso Features to facilitate stochastic differential equations (SDE).This notice is not a request for proposal and a solicitation will not be issued in conjunction with the notice of intent. Any vendor that believes it can provide the stated supplies/equipment can provide supporting documents demonstrating their products capability and specifications statement. The FDA will review all responses received; however, the Government retains the sole discretion not to further compete the proposed acquisition based on responses to this notice. Information can be sent to Jody O'Kash at Jody.OKash@fda.hhs.gov. All correspondence must contain the notice number: FDA-18-PRESOL-1198202 and Project Title: ICON NONMEM. No telephone or facsimile requests will be accepted.
FDA-18-PRESOL-1198202
Department of Health and Human Services Food and Drug Administration
Award Notice 1/1
6/12/18, 5:56 PM
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
- NONMEM SOFTWARE - NECESSARY FOR CLINICAL PHARMACOLOGY REVIEWERS AND PHARMACOMETRICIANS.
Not listed
$10.0k
7/18/18